Markers of aneurysm formation and progression

  • Research type

    Research Study

  • Full title

    Markers of the susceptibility to aneurysm formation and progression

  • IRAS ID

    163467

  • Contact name

    Alberto Smith

  • Contact email

    alberto.smith@kcl.ac.uk

  • Duration of Study in the UK

    5 years, 0 months, 0 days

  • Research summary

    An arterial aneurysm (AA) is a ballooning of a blood vessel that carries blood from the heart to the tissues around the body. This is a common condition, with rupture of AA, accounting for 1-2% of all deaths in the UK each year.
    Familial predisposition is a strong risk factor in the development of aneurysms. Between 15-20% of patients with abdominal aortic aneurysms (AAA) and over 20% with thoracic aneurysms (TAA) inherit this condition, with approximately 7-fold increase in the prevalence of (AAA) in the brothers of affected individuals and an 18-fold increase in brothers aged over 60 years. Patients with a family history tend to present younger and have a greater rate of rupture.
    Genetic studies of aneurysmal disease have focused primarily on common genetic risk factors in the population through the application of genome-wide association studies (GWAS) that compare the profiles of known sequences in the molecules that make up the DNA of affected individuals with that of the normal population. Although GWAS data reveals interesting biological information, the size of the effect of identified common variants are modest and have very little predictive value. It is clear from our population studies that there must be rare variants, which produce stronger effects that explain the heritability of aneurysms.
    The aim of this study is to use innovative gene sequencing technologies to identify novel gene variants that predispose to aneurysmal disease. Finding such variants in subjects with aneurysmal disease, in conjunction with identification of circulating biomarkers of disease, would provide useful prognostic information in first-degree relatives before an aneurysm develops and might highlight putative targets for medical therapy.

  • REC name

    London - Westminster Research Ethics Committee

  • REC reference

    15/LO/0625

  • Date of REC Opinion

    15 Jun 2015

  • REC opinion

    Further Information Favourable Opinion